Integrated Biomarker And Imaging Study - 2

• Status: Completed
• Trial end date: 2007-08-28

Summary

IBIS-2 is a study using SB-480848 versus placebo in subjects with angiographically documented coronary heart disease. Endpoints include coronary imaging, endothelial function, biomarkers, safety and tolerability.

• Phase: Phase 2

Details

• Lead Sponsor: GlaxoSmithKline